Water・Resource Circulation

Water Stewardship

Good quality and sufficient quantities of fresh water are essential to our business activities, including pharmaceutical research, development, and manufacturing. As water-related challenges continue to intensify globally, we are committed to the sustainable use of water resources while advancing our efforts to identify, assess, and manage water-related risks.

 

Effective Use of Water Resources

To use water resources in a sustainable manner, we have established a Medium- to Long-term Environmental Goal of reducing water withdrawal to no more than the fiscal 2020 level (599 kt*1) by fiscal 2030. To reduce water withdrawal, we monitor and manage water withdrawal and wastewater discharge across all group business sites, excluding small offices such as tenant offices. We also implement Group-wide measures, including the installation of water-efficient equipment and the optimization of air-conditioning system operations. At our production and research sites, we implement site-specific initiatives to reduce water withdrawal, such as optimizing the frequency of equipment cleaning and installing water-saving nozzles on faucets used in animal care facilities.

In fiscal 2025, water withdrawal decreased compared with the previous fiscal year due to the downsizing of active pharmaceutical ingredient (API) manufacturing functions at domestic production sites. We will continue to improve water-use efficiency and promote water conservation measures to further reduce water withdrawal.

For more information on the progress of the Medium- to Long-term Environmental Goals, please see "Environmental Goals and Performance."

  • *1Water withdrawal in fiscal 2020, excluding water withdrawal associated with the downsized API manufacturing operations.

Water Withdrawal Reduction Targets and Transition (Non-Consolidated)

Water Withdrawal Reduction Targets and Transition (Non-Consolidated)

Water Withdrawal by Source (Consolidated)

Water Withdrawal by Source (Consolidated)

Water Discharged and Breakdown by Discharge Destination (Consolidated)

Water Discharged and Breakdown by Discharge Destination (Consolidated)

Boundary of calculation:
Consolidated basis (Sumitomo Pharma Co., Ltd., consolidated subsidiaries in Japan, overseas consolidated subsidiaries), excluding small offices such as sales offices. Overseas consolidated subsidiaries that do not have production sites or major research facilities are excluded from the scope because they have only small offices.

For more information on the calculation standards, please see "ESG Data Table."

Water Risk Assessment

We regularly assess risks related to current and future water stress and downstream environmental vulnerability at our production and research sites using the World Resources Institute (WRI) Aqueduct water risk assessment tool, the Integrated Biodiversity Assessment Tool (IBAT), and other assessment tools. In addition, through interview surveys of staff at our production and research sites, we have investigated past water-related problems as well as future region-specific issues at each site. Although some sites are located in water-stressed areas, our comprehensive assessment, considering factors such as site-level water withdrawal and local water supply conditions, indicates that risks related to water availability and downstream environmental vulnerability at our production and research sites are currently considered to be low.

Water-related risks and opportunities associated with climate change, including flooding, are managed through our company-wide risk management promotion framework under the oversight of the Board of Directors. We continue to conduct analyses and assessments in line with the Task Force on Climate-related Financial Disclosures (TCFD) recommendations and implement measures to mitigate identified risks.

For more information, please see "Information Disclosure Based on TCFD Recommendations (Response to Climate Change)."

In our assessment of nature-related issues based on the Task Force on Nature-related Financial Disclosures (TNFD) recommendations, “Water Resources (Dependency)” has been identified as one of our key issues, and information on related risks is disclosed.
For more information, please see "Biodiversity".

As part of our value chain risk management, we continue to evaluate water risks of raw material manufacturers for important products and contract manufacturers using Aqueduct. Additionally, through sustainability evaluation based on our Sustainable Code of Conduct for Business Partners, we confirm our business partners' management of water withdrawal and wastewater discharge, wastewater pollutant controls, and water-saving/recycling initiatives. We will continue to strengthen engagement with our business partners and work to reduce water-related risks across the value chain.

For more information on the Sustainability Survey, please see "Together with Business Partners" and "Environmental Communications."

Results of Water Stress Assessments Using WRI Aqueduct (Target: Production and Research Sites of the Sumitomo Pharma Group)

Level of water stress Japan Overseas
Number of sites Fiscal 2025 water withdrawal (kt) Number of sites Fiscal 2025 water withdrawal (kt)
Low(<10%) ー ー ー ー
Low - Medium(10-20%) 4 549 1 (U.S.) 9
Medium - High(20-40%) ー ー ー ー
High(40-80%) ー ー ー ー
Extremely High(>80%) ー ー 2 (China, U.S.) 8
Total 4 549 3 17

Resource Circulation

We believe that promoting resource circulation contributes to reducing environmental impacts and improving operational efficiency through the effective use of limited resources. Based on this approach, we have established the following Medium- to Long-term Environmental Goals and are actively promoting the 3Rs of waste management (reduce, reuse, and recycle).

  • Maintain recycling rate at 80% or higher and aim for at least 85% by fiscal 2030.
  • Maintain final disposal rate at less than 1% and aim for less than 0.5% by fiscal 2030.
  • Achieve plastic waste recycling rate of 65% or more by fiscal 2030.

To reduce waste and promote recycling, we implement the following initiatives:

  • Material recycling of blister packaging waste generated during packaging processes*2
  • Recycling of non-dispersive asbestos-containing waste, which was previously subject to final disposal
  • Active adoption of environmentally friendly containers and products, such as bottle cans, in vending machines at each business site, as part of efforts to reduce PET bottle usage
  • Sale of unused laboratory equipment to promote reuse*3
  • Participation in a recycling initiative using the material recycling platform operated by Askul Corporation in which used plastic folders are collected for recycling*4

In fiscal 2025, we achieved our targets for both the recycling rate and final disposal rate for the third consecutive year. The plastic waste recycling rate declined to 62%, falling below the previous year's level due to the suspension of recycling services for blister packaging waste.

Going forward, we will actively pursue recycling through thorough waste separation, conversion of waste into valuable resources and outsourcing to waste management contractors capable of recycling waste.

For more information on the progress of the Medium- to Long-term Environmental Goals, please see "Environmental Goals and Performance."

Waste-related Indicators

Recycling Rate
recycling reate of waste
Final Disposal Rate
Final disposal rate of waste

Boundary of calculation: Sumitomo Pharma Co., Ltd. only (Sales offices are excluded. For the plastic waste recycling rate, the head office and sales offices are excluded).

For more information on the calculation standards, please see "ESG Data Table."

Recycling of Product Containers and Packaging Materials

In accordance with the Containers and Packaging Recycling Act, Sumitomo Pharma recycles some of the containers and packaging materials used for our products.
Going forward, we will also fulfill our obligation to recycle containers and packaging, and actively work on reducing the amount of packaging materials used and replacing them with renewable resources.

Usage of Product Containers and Packaging Materials, Outsourced Recycling Amounts*5(Fiscal 2024 results)
Product containers and packaging materials Usage (t) Outsourced recycling amount (t)
Plastic 330 107
Glass 37 0
Paper 207 6

Total Recycling Commission Fee: 7,679,000 yen

  • *5Outsourced recycling amounts are calculated based on coefficients for calculating mandatory recycling amounts determined by the Japanese Government.